Change of Director's Interest Notice
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
PharmAust Limited
Name of entity
ABN
35 094 006 023
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director
Mr Sam Michael Wright
Date of last notice
13 November 2014
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
The securities are held by Straight Lines
Consultancy Pty Ltd as trustee for the
Straight Lines Consultancy Trust. Mr Wright
is a Director of Straight Lines Consultancy
Pty Ltd and a Beneficiary of the Straight
Lines Consultancy Trust.
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change
11 August 2015
No. of securities held prior to change
5,500,000 Ordinary Fully Paid Shares
375,000 Listed Options (ASX:PAAO)
Class
Ordinary Fully Paid Shares
Number acquired
1,000,000 Ordinary Fully Paid Shares
Number disposed
Nil
Value/Consideration
$7,000.00
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change
6,500,000 Ordinary Fully Paid Shares
375,000 Listed Options (ASX:PAAO)
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
On-market trade
+ See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
Part 3 – +Closed period
Were the interests in the securities or contracts detailed
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was
this provided?
No
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Share your feedback
Discover